This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Thematic or Momentum ETFs?

The following commentary comes from an independent investor or market observer as part of TheStreet's guest contributor program, which is separate from the company's news coverage.

NEW YORK ( ETF Expert) -- Scores of investment gurus live on momentum and relative strength. They may advocate investing solely in those assets that have put together streaks over four, eight and 12 weeks.

Other media darlings don't care what happens in a shorter period. They may run with a particular theme for decades. For instance, Jim Rogers likes commodities and the China growth story, despite the bumps that may occur along the path.

Sometimes, the hottest three-month winners are the same investments that fit a longer-term premise. For example, in 2009 as well as in parts of 2010, commodities and commodity-rich nations benefited from U.S. government decisions that weakened the U.S. dollar. Those that believe in the dollar's demise over the long-term profited in shorter-term periods as well as year-over-year periods.

Some longer-term themes fall on deaf ears. The notion of cheap P/Es and an aging baby boomer demographic didn't help healthcare-related stocks in 2009 or 2010; healthcare-related stocks severely underperformed in year-over-year periods as well as longer-term time frames.

Interestingly enough, health care has rocketed year to date . Pharma ETFs and Biotech ETFs even look pretty sharp over the last 12 weeks, showing tremendous relative strength.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
SYM TRADE IT LAST %CHG
THD $77.99 -1.30%
XLU $44.49 -0.34%
EWM $13.33 -1.30%
EWS $13.41 -0.30%
AAPL $132.76 1.00%

Markets

DOW 18,265.15 -20.59 -0.11%
S&P 500 2,130.63 -0.19 -0.01%
NASDAQ 5,102.7410 +11.9470 0.23%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs